BOGOTA, Colombia – Proposed regulations in Colombia that would eliminate the need for trials for some biotech products have drawn heat from multinational companies and regulators abroad.

BOGOTA, Colombia – As the political and economic situation worsens in Venezuela, pharmaceutical and biotech companies in the Latin American country are among the most affected by a lack of access to foreign currency.

BOGOTA, Colombia – During the Cold War, Soviet researchers studied the medical applications of bacteriophages, viruses that attack bacteria, but remained isolated from advances in antibiotics on the other side of the Iron Curtain.

BOGOTA, Colombia – French health care company Stallergenes SA announced the acquisition of Argentina's Alergo Pharma Srl as part of a plan to boost its presence in Latin America, while focusing on the diagnosis and treatment of allergies through diverse allergen immunotherapy-based solutions.

BOGOTA, Colombia – A shortage of pentavalent and hexavalent vaccines that left children in Latin America and Europe exposed to a series of preventable diseases for months may have been resolved, but countries are still trying to fill in the gaps.